MARTIN TAYLOR: Open Payments
NPI 1578535092 · ONALASKA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 14 payments from 9 companies in 2025. Trend: 2023 $771 · 2024 $620 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $153 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| ABBVIE INC. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Exact Sciences Corporation | 2 | $35 |
| Dexcom, Inc. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: AIRSUPRA, REXULTI, MAVYRET, CAPLYTA, Dexcom G6 Transmitter, Ohtuvayre, Cologuard Collection Kit, XYOSTED.
Industry payments across TX — which companies pay providers there.
